Giacomo Di Colo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giacomo Di Colo has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ylenia Zambito
Department of Pharmacy, University of Pisa, Pisa, Italy
13 shared publications S Burgalassi
Department of Bioorganic Chemistry and Biopharmaceutics, University of Pisa, Via Bonanno 33, Pisa 56126, Italy
4 shared publicationsM.F Saettone
Department of Bioorganic Chemistry and Biopharmaceutics, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy
3 shared publications- Patrizia Chetoni
Department of Pharmacy - University of Pisa, Italy
3 shared publications A. Baggiani
Department of Bioorganic Chemistry and Biopharmaceutics, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy
2 shared publicationsChiara Zaino
Department of Bioorganic Chemistry and Biopharmaceutics, University of Pisa, Pisa, Italy
2 shared publications
Latest Publications
- 19 May 2009
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 35 (8) , 941-949
Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model
Mucoadhesive polysaccharides may prolong the residence of ophthalmic drugs in precorneal area. In this article, the mucoadhesiveness of arabinogalactan, tamarind seed polysaccharide, hyaluronan, hydroxyethylcellulose is compared in vivo, by the polymer residence time in rabbit tear fluid, and in vitro, by the polymer-induced increase of viscosity of a mucin dispersion. Polymer residence is prolonged by increased viscosity but shortened by reflex tearing caused by excessive viscosity. Tamarind seed polysaccharide is the most effective in prolonging the residence of ketotifen and diclofenac in precorneal area; hence, it is the optimal eyedrop additive as it is mucoadhesive while not increasing viscosity excessively.
- 19 May 2009
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 35 (8) , 941-949
Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model
Mucoadhesive polysaccharides may prolong the residence of ophthalmic drugs in precorneal area. In this article, the mucoadhesiveness of arabinogalactan, tamarind seed polysaccharide, hyaluronan, hydroxyethylcellulose is compared in vivo, by the polymer residence time in rabbit tear fluid, and in vitro, by the polymer-induced increase of viscosity of a mucin dispersion. Polymer residence is prolonged by increased viscosity but shortened by reflex tearing caused by excessive viscosity. Tamarind seed polysaccharide is the most effective in prolonging the residence of ketotifen and diclofenac in precorneal area; hence, it is the optimal eyedrop additive as it is mucoadhesive while not increasing viscosity excessively.
- 1 May 2008
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 97 (5) , 1652-1680
Polymeric Enhancers of Mucosal Epithelia Permeability: Synthesis, Transepithelial Penetration-Enhancing Properties, Mechanism of Action, Safety Issues
- 1 May 2008
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 97 (5) , 1652-1680
Polymeric Enhancers of Mucosal Epithelia Permeability: Synthesis, Transepithelial Penetration-Enhancing Properties, Mechanism of Action, Safety Issues
- Open Access
- 26 December 2007
- Published by Bentham Science Publishers Ltd. in The Open Drug Delivery Journal
- Vol. 1 (1) , 68-75
A Novel Polyelectrolyte Complex (PEC) Hydrogel for Controlled Drug Delivery to the Distal Intestine
A Novel Polyelectrolyte Complex (PEC) Hydrogel for Controlled Drug Delivery to the Distal Intestine
- 26 December 2007
- Published by Bentham Science Publishers Ltd. in The Open Drug Delivery Journal
- Vol. 1 (1) , 68-75
Open AccessA Novel Polyelectrolyte Complex (PEC) Hydrogel for Controlled Drug Delivery to the Distal Intestine
A Novel Polyelectrolyte Complex (PEC) Hydrogel for Controlled Drug Delivery to the Distal Intestine
- 9 March 2006
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 310 (1-2) , 154-161
A new hydrogel for the extended and complete prednisolone release in the GI tract
- 9 March 2006
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 310 (1-2) , 154-161
A new hydrogel for the extended and complete prednisolone release in the GI tract
- 1 May 2005
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (5) , 565-571
A site-specific controlled-release system for metformin
Oral absorption of the antihyperglycaemic agent metformin hydrochloride (MF-HCl) is confined to the upper part of the intestine, therefore rational controlled-release formulations of this drug should ensure a complete release during transit from stomach to jejunum. The aim of this study was the preparation of a system able to sustain release of high MF-HCl doses in compliance with the above requirement. Matrices (6 mm diameter; 50 mg weight) comprising varying drug-Precirol ATO 5 ratios were prepared by compression. The matrix containing 70% drug was coated on one face with Eudragit L100–55. Drug release to simulated gastric (SGF), jejunal (SJF) and ileal (SIF) fluids in sequence was studied using a modified USP rotating basket method. Release depended on drug load whereas it was independent of dissolution medium pH and hydrodynamics. Release kinetics were of √t type and were determined by drug diffusion in aqueous pores created in the matrix by drug dissolution. An equation correlating rate-determining factors was developed, whereby the release pattern could be optimized. The half-coated matrix started release in SGF and completed it in SJF. The half-coated matrix, synchronizing drug release and matrix transit across the small intestine, may improve drug bioavailability and reduce side effects.
- 1 May 2005
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (5) , 565-571
A site-specific controlled-release system for metformin
Oral absorption of the antihyperglycaemic agent metformin hydrochloride (MF-HCl) is confined to the upper part of the intestine, therefore rational controlled-release formulations of this drug should ensure a complete release during transit from stomach to jejunum. The aim of this study was the preparation of a system able to sustain release of high MF-HCl doses in compliance with the above requirement. Matrices (6 mm diameter; 50 mg weight) comprising varying drug-Precirol ATO 5 ratios were prepared by compression. The matrix containing 70% drug was coated on one face with Eudragit L100–55. Drug release to simulated gastric (SGF), jejunal (SJF) and ileal (SIF) fluids in sequence was studied using a modified USP rotating basket method. Release depended on drug load whereas it was independent of dissolution medium pH and hydrodynamics. Release kinetics were of √t type and were determined by drug diffusion in aqueous pores created in the matrix by drug dissolution. An equation correlating rate-determining factors was developed, whereby the release pattern could be optimized. The half-coated matrix started release in SGF and completed it in SJF. The half-coated matrix, synchronizing drug release and matrix transit across the small intestine, may improve drug bioavailability and reduce side effects.
- 1 January 2005
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 15 (5) , 397-402
Design and in vitro evaluation of an extended-release matrix tablet for once-daily oral administration of oxybutynin
- 1 January 2005
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 15 (5) , 397-402
Design and in vitro evaluation of an extended-release matrix tablet for once-daily oral administration of oxybutynin
- 1 November 2004
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (11) , 2851-2862
Effects of Different N-Trimethyl Chitosans on In Vitro/In Vivo Ofloxacin Transcorneal Permeation
- 1 November 2004
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (11) , 2851-2862
Effects of Different N-Trimethyl Chitosans on In Vitro/In Vivo Ofloxacin Transcorneal Permeation
- 1 April 2004
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 273 (1-2) , 37-44
Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin
- 1 April 2004
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 273 (1-2) , 37-44
Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin
- 1 November 2002
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 248 (1-2) , 115-122
Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide)
- 1 November 2002
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 248 (1-2) , 115-122
Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide)
- 1 September 2002
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 54 (2) , 193-199
A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide)
- 1 September 2002
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 54 (2) , 193-199
A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide)